Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr₹6,315 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹9,151 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr
Mar2021₹6,315 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr
3.87
Mar2021 ₹6,315 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,755.9 Cr -3.8% -8.6% -32.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,590.0 Cr -2% -6.1% -6.7% Stock Analytics
DIVIS LABORATORIES ₹170,577.0 Cr -0.8% -0.8% 8.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,301.0 Cr 0% 2.7% 11% Stock Analytics
CIPLA ₹120,471.0 Cr -0.6% -2.6% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,660.0 Cr -1.3% 0.6% -6.4% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-3.8%

-8.6%

-32.8%

SENSEX

-1%

-1.2%

7.9%


You may also like the below Video Courses